Glenview, Ill. (October 1, 2015)--Persistent, unexplained cough is a significant health issue that occurs in up to 5-10 percent of patients seeking medical assistance for chronic cough. Patients experience significant quality of life impairment with chronic cough lasting for many months or years, despite attempts at treatment. In this latest evidence-based guideline from the American College of Chest Physicians, experts provide six recommendations for appropriate treatment of patients with unexplained chronic cough, including the use of speech pathology based cough suppression as a treatment option.
"This guideline chapter, another from CHEST living guidelines, provides the most up-to-date treatment options for patients living with unexplained chronic cough. The guideline presents suggestions for diagnosis and treatment based on the best available evidence and identifies gaps in our knowledge and areas for future research," said Richard S. Irwin, MD, Master FCCP, and Diagnosis and Management of Cough: CHEST Evidence-Based Clinical Practice Guidelines Chair.
To date, the updated guideline has been endorsed by the American Academy of Otolaryngology- Head and Neck Surgery, American Association for Respiratory Care, American Thoracic Society, Irish Thoracic Society, and Lung Foundation Australia.
The complete guideline chapter is free to view in the Online First section of the journal CHEST: http://bit.
About CHEST Living Guidelines Living guidelines are systematically developed, evidence-based, and continually updated recommendations for the diagnosis and management of medical conditions. These guidelines are intended to inform both healthcare providers and patients in making educated clinical decisions.
American College of Chest Physicians (CHEST), publisher of the journal CHEST, is the global leader in advancing best patient outcomes through innovative chest medicine education, clinical research, and team-based care. Its mission is to champion the prevention, diagnosis, and treatment of chest diseases through education, communication, and research. CHEST serves as an essential connection to clinical knowledge and resources for its 18,700 members from around the world who provide patient care in pulmonary, critical care, and sleep medicine. CHEST Enterprises, Inc, a wholly owned subsidiary of CHEST, provides innovative education for health-care professionals and industry partners to advance best patient outcomes.
For more information, visit chestnet.org.